Gabapentin: A single retrospective study of gabapentin in patients with PTSD showed a marked or moderate improvement in sleep, as well as a decreased frequency or intensity of nightmares. 28 Nabilone: In a single open-label study, the majority of PTSD patients receiving nabilone experienced cessation of nightmares or a significant reduction in OBJECTIVE: This article describes current approaches to the pharmacologic treatment of posttraumatic stress disorder (PTSD) and reviews the classes of pharmacologic agents used in the treatment of PTSD. Pharmacotherapy for PTSD that is comorbid with other psychiatric disorders is highlighted. METHODS: The primary-source literature was reviewed by using a MEDLINE search. Secondary-source review Gabapentin, a novel anticonvulsant agent, has been of interest as a potential anxiolytic agent, but has not been evaluated in PTSD. We reviewed records of 30 consecutive patients who had been diagnosed with PTSD according to structured interviews and had received gabapentin as an adjunctive medication. Gabapentin has clearer efficacy for alcohol craving and withdrawal symptoms and may have a role in adjunctive treatment of opioid dependence. There is no clear evidence for gabapentin therapy in depression, PTSD prevention, OCD, or other types of substance abuse. Gabapentin’s potential in addressing PTSD symptoms lies in its ability to modulate neurotransmitter activity and influence these dysregulated brain systems. By affecting calcium channels, gabapentin may help reduce the excessive neuronal excitability often seen in PTSD. OBJECTIVE:To report the effects of gabapentin in a patient with concurrent depression and posttraumatic stress disorder (PTSD) and review the use of antiepileptic drugs (AEDs) in PTSD.CASE SUMMARY: A recent systematic review concluded that gabapentin for alcohol use disorder may be safe only as an adjuvant but not as a monotherapy and that there is insufficient evidence to support its use as a treatment for other substance dependencies or for depression, OCD, PTSD, and schizoaffective disorder . The largest proportion of off-label Gabapentin has less likely benefit adjunctively for bipolar disorder. Gabapentin has clearer efficacy for alcohol craving and withdrawal symptoms and may have a role in adjunctive treatment of opioid dependence. There is no clear evidence for gabapentin therapy in depression, PTSD prevention, OCD, or other types of substance abuse. Post-traumatic stress disorder (PTSD) can develop after any trauma — from military service to a natural disaster. gabapentin (Neurontin) oxcarbazepine (Trileptal) topiramate (Topamax) Posttraumatic stress disorder (PTSD) symptoms may improve significantly with antidepressant medications, however some phenomena often remain refractory to the most commonly used treatments. Frequently, sleep disturbances, such as insomnia and nightmares, are symptoms of PTSD that are refractory to antidepressant treatment. Gabapentin, a novel anticonvulsant agent, has been of interest as a The gabapentinoids, gabapentin, and pregabalin, target the α2δ subunits of voltage-gated calcium channels. Initially licensed for pain and seizures, they have become widely prescribed drugs. A case is presented in which a patient diagnosed with posttraumatic stress disorder (PTSD) who had been taking multiple medications with little clinical response was placed on gabapentin treatment with beneficial results. Objective: To report the effects of gabapentin in a patient with concurrent depression and posttraumatic stress disorder (PTSD) and review the use of antiepileptic drugs (AEDs) in PTSD. Case summary: A 37-year-old Latin American woman was being treated for major depression and PTSD. In addition to propranolol and hydrocortisone, observational studies have associated early morphine use with reduced rates of PTSD 21 and other drugs, including SSRIs 22, gabapentin 23, α-omega We reviewed records of 30 consecutive patients who had been diagnosed with PTSD according to structured interviews and had received gabapentin as an adjunctive medication. For each patient, the Clinician's Guide to Medications for PTSD. Paul Holtzheimer, MD and Macgregor Montaño, PharmD, BCPP. The 2023 VA/DoD Clinical Practice Guideline (CPG) for PTSD recommends specific trauma-focused psychotherapies as first-line treatments for PTSD over pharmacotherapy (1). Gabapentin has less likely benefit adjunctively for bipolar disorder. Gabapentin has clearer efficacy for alcohol craving and withdrawal symptoms and may have a role in adjunctive treatment of opioid dependence. There is no clear evidence for gabapentin therapy in depression, PTSD prevention, OCD, or other types of substance abuse. Evidence does not support the use of gabapentin for bipolar disorder, major depressive disorder (MDD), posttraumatic stress disorder (PTSD), obsessive compulsive disorder (OCD), stimulant use disorder, or opioid withdrawal. This retrospective study suggests that gabapentin may improve in particular sleep difficulties and also other symptoms associated with chronic PTSD. Prospective, controlled studies are needed to further investigate the effects of gabapentin on insomnia, nightmares, and other core PTSD symptoms. Keywords: gabapentin, neurontin, bipolar disorder, substance use disorder, alcohol use disorder, alcohol withdrawal, PTSD, anxiety disorder Citation: Ahmed S, Bachu R, Kotapati P, Adnan M, Ahmed R, Farooq U, Saeed H, Khan AM, Zubair A, Qamar I and Begum G (2019) Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: A
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |